Cargando…
NK cell upraise in the dark world of cancer stem cells
One of the obstacles in treating different cancers, especially solid tumors, is cancer stem cells (CSCs) with their ability in resistance to chemo/radio therapy. The efforts for finding advanced treatments to overcome these cells have led to the emergence of advanced immune cell-based therapy (AICBT...
Autores principales: | Shokouhifar, Alireza, Firouzi, Javad, Nouri, Masoumeh, Sarab, Gholamreza Anani, Ebrahimi, Marzieh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8684645/ https://www.ncbi.nlm.nih.gov/pubmed/34923966 http://dx.doi.org/10.1186/s12935-021-02400-1 |
Ejemplares similares
-
Overcoming the UCB HSCs –Derived NK cells Dysfunction through Harnessing RAS/MAPK, IGF-1R and TGF-β Signaling Pathways
por: Shokouhifar, Alireza, et al.
Publicado: (2021) -
Silibinin exhibits anti-tumor effects in a breast cancer stem cell model by targeting stemness and induction of differentiation and apoptosis
por: Firouzi, Javad, et al.
Publicado: (2022) -
Upraising Stenotrophomonas maltophilia in Critically Ill Patients: A New Enemy?
por: Dimopoulos, George, et al.
Publicado: (2023) -
Hsp70, in Combination with IL-15 and PD-1 Blocker, Interferes
with The Induction of Cytotoxic NK Cells in Relapsed Acute
Myeloid Leukemia Patients
por: Firouzi, Javad, et al.
Publicado: (2023) -
CD133 Is Not Suitable Marker for Isolating Melanoma
Stem Cells from D10 Cell Line
por: Rajabi Fomeshi, Motahareh, et al.
Publicado: (2016)